Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 11, Number 10, October 2019, pages 682-689

Management of Esophageal Achalasia in Quebec

Figures

Figure 1.
Figure 1. Age distribution of patients with esophageal achalasia.
Figure 2.
Figure 2. Eckardt score distribution after treatment of esophageal achalasia.
Figure 3.
Figure 3. Comparison of post-treatment Eckardt score depending on the type of treatment for esophageal achalasia.
Figure 4.
Figure 4. Comparison of post-treatment Eckardt score depending on the delay after the treatment for esophageal achalasia.
Figure 5.
Figure 5. Percentage of patients taking proton pump inhibitor depending on the type of treatment for esophageal achalasia.
Figure 6.
Figure 6. Percentage of patients taking proton pump inhibitor depending on the delay after the treatment for esophageal achalasia.
Figure 7.
Figure 7. Percentage of patients needing a second treatment depending on the type of treatment for esophageal achalasia.
Figure 8.
Figure 8. Comparison of the management of patients treated at the CHUM vs. outside CHUM for esophageal achalasia.
Figure 9.
Figure 9. Comparison of post-treatment Eckardt score depending on the site of treatment for esophageal achalasia.
Figure 10.
Figure 10. Percentage of patients taking proton pump inhibitor depending on the site of treatment for esophageal achalasia.

Table

Table 1. Characteristics of Patients Depending on the Type of Treatment Received
 
Heller myotomyBotox injectionDilationPOEMMedical treatment
POEM: peroral endoscopic myotomy.
Patients, n (%)79 (60)24 (18)22 (16)4 (3)3 (2)
Mean age, years5168545662
Male sex, n (%)37 (47)11 (46)16 (73)3 (75)1 (33)
Female sex, n (%)42 (53)13 (54)6 (27)1 (25)2 (67)